结肠在柳氮磺胺吡啶代谢中的作用。 - Suppr

Suppr

超能文献

The role of the colon in the metabolism of salicylazosulphapyridine.

作者信息

Das K M, Eastwood M A, McManus J P, Sircus W

出版信息

Scand J Gastroenterol. 1974;9(2):137-41.

PMID:4150441

Abstract

摘要

相似文献

The role of the colon in the metabolism of salicylazosulphapyridine.

Scand J Gastroenterol. 1974;9(2):137-41.

[Estimations of the serum levels of sulfapyridine on patients treated with sulfasalazin (author's transl)].

Dtsch Z Verdau Stoffwechselkr. 1982;42(1):14-9.

Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.

N Engl J Med. 1973 Sep 6;289(10):491-5. doi: 10.1056/NEJM197309062891001.

[Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].

Dtsch Med Wochenschr. 1986 May 2;111(18):721-2.

Simplified high-performance liquid chromatographic method for 5-aminosalicylic acid in plasma and urine.

J Chromatogr. 1981 Oct 9;225(2):498-503. doi: 10.1016/s0378-4347(00)80303-5.

Sulphasalazine in inflammatory bowel disease: recent advances.

N Z Med J. 1986 Oct 8;99(811):757-9.

The effect of salazopyrin on water and electrolyte transport in the human colon measured in vivo and in vitro.

Gut. 1972 Oct;13(10):855.

[Determination of sulfapyridine levels in serum--a possibility for the control of dose related therapy with sulfasalazine].

Dtsch Z Verdau Stoffwechselkr. 1984;44(6):282-8.

[40 years of salazosulfapyridine. Is end in sight?].

Ned Tijdschr Geneeskd. 1982 Oct 30;126(44):2014-8.

[Colitis--newer aspects upon ulcerative colitis and Crohn's disease in the colon].

Lakartidningen. 1973 Sep 5;70(36):3051-71.

引用本文的文献

Amino acid derivatives of 5-ASA as novel prodrugs for intestinal drug delivery.

Dig Dis Sci. 1994 Dec;39(12):2601-6. doi: 10.1007/BF02087696.

Sulfasalazine. Adverse effects and desensitization.

Dig Dis Sci. 1983 Sep;28(9):833-42. doi: 10.1007/BF01296907.

4-Aminosalicylic acid retention enemas in treatment of distal colitis.

Dig Dis Sci. 1987 Jul;32(7):700-4. doi: 10.1007/BF01296134.

5-Aminosalicylic acid in patients with an ileo-rectal anastomosis. A comparison of the fate of sulfasalazine and Pentasa.

Eur J Clin Pharmacol. 1986;31(1):23-6. doi: 10.1007/BF00870980.

5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?

Drugs. 1986;32 Suppl 1:27-34. doi: 10.2165/00003495-198600321-00006.

Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.

Clin Pharmacokinet. 1985 Jul-Aug;10(4):285-302. doi: 10.2165/00003088-198510040-00001.

Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Clin Pharmacokinet. 1990 Aug;19(2):94-125. doi: 10.2165/00003088-199019020-00002.

Effects of olsalazine and sulphasalazine on jejunal and ileal water and electrolyte absorption in normal human subjects.

Gut. 1991 Mar;32(3):270-4. doi: 10.1136/gut.32.3.270.

Sulfasalazine. Multiplicity of action.

Dig Dis Sci. 1992 Jun;37(6):801-12. doi: 10.1007/BF01300376.

Salicylazosulfapyridine in inflammatory bowel disease.

Am J Dig Dis. 1975 Oct;20(10):971-6. doi: 10.1007/BF01070886.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验